Zen Technologies Limited · NSE:ZENTEC
Zen Technologies — Q1 FY2026 Earnings Presentation
13 slides from Zen Technologies's earnings presentation, Jul 27, 2025
Slide 1: Exchange filing cover letter
July 27, 2025 To To Listing Department Dept. of Corp. Services National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G, Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Dalal Street Bandra (E), Mumbai – 400 051 Mumbai- 400001 Symbol: ZENTEC Scrip Code: 533339 Dear Sir/Madam,
Slide 2: Investor Presentation Q1FY26
Investor Presentation Q 1 F Y 2 6 NSE : ZENTEC BLOOMBERG : ZEN IN B SE : ZENTEC - 533339 REUTERS : ZETE . BO
Slide 3: Management Commentary
Management Commentary Mr Ashok Atluri CHAIRMAN & MANAGING DIRECTOR “Our Q1FY26 results reflect moderation in topline marks expansion into the high-growth UAV and loitering growth, we believe this is a temporary adjustment phase munitions segment, aligning our portfolio with emerging with a much stro
Slide 4: Strengthening Strategic Capabilities through Targeted Acquisitions
Strengthening Strategic Zen Technologies has completed four strategic acquisitions. These transactions mark a decisive move to diversify our capabilities, deepen our technological edge, Capabilities and expand our market reach across land, air, and sea defence domains. through Targeted Applied Resea
Slide 5: Quarterly Standalone Highlights
Quarterly Standalone Revenue from Operations (YoY) Operational EBITDA (YoY) Profit After Tax (YoY) Highlights (All Values ₹ in Crore) (All Values ₹ in Crore) (All Values ₹ in Crore) 253.96 103.20 80.00 74.18 70.00 60.00 111.06 37.12 50.00 38.05 40.00 30.00 20.00 10.00 0.00 Q1FY25 Q1FY26 Q1FY25 Q1FY2
Slide 6: Quarterly Consolidated Highlights
Quarterly Consolidated Revenue from Operations (YoY) Operational EBITDA (YoY) Profit After Tax (YoY) Highlights (All Values ₹ in Crore) (All Values ₹ in Crore) (All Values ₹ in Crore) 254.62 111.35 76.81 *PAT Adjusted for Non-Controlling Interests 47.75 158.22 64.70 Q1FY25 Q1FY26 Q1FY25 Q1FY26 Q1FY2
Slide 7: Consolidated Order Book
Consolidated Order Book Status as of 30 June 2025 Order New Orders Book + Orders - Executed = TotalBook Order Order Book as at New Order bagged Orders executed Order Book as at 1st April 2025 in Q1FY26 in Q1FY26 30th June 2025 Total: Total: Total: Total: 848.52 Cr 64.26 Cr 158.22 Cr 754.56 Cr *Note:
Slide 8: Diversified Consolidated Order Book
Diversified Consolidated Order Book Total + = 754.56 Domestic Export 637.15 117.41 *Note: Order book as at 30th June 2025 includes ₹ 148.58 Cr relating to subsidiaries companies. 7
Slide 9: Financial Statement Summary (Standalone)
Financial Statement Summary Summary of Standalone Profit & Loss Statement Particulars Q1FY26 Q4FY25 Q1FY25 (₹ in Crore) (Unaudited) (Audited) (Unaudited) KEY PERFORMANCE INDICATORS Sales 111.06 293.50 253.96 Other Operating Revenue 19.89 24.36 3.05 Total Revenue 130.95 317.85 257.00 Total Operating
Slide 10: Financial Statement Summary (Consolidated)
Financial Statement Summary Summary of Consolidated Profit & Loss Statement Particulars Q1FY26 Q4FY25 Q1FY25 (₹ in Crore) (Unaudited) (Audited) (Unaudited) KEY PERFORMANCE INDICATORS Sales 158.22 324.97 254.62 Other Operating Revenue 21.79 24.77 3.11 Total Revenue 180.01 349.74 257.73 Total Operatin
Slide 11: Quarterly R&D Spends over the Years
Quaterly R&D Spends over the Years (in crores) 8 7 6.99 6.97 6 5 4.89 4.15 4 3.39 3 2 1 0 Q1FY22 Q1FY23 Q1FY24 Q1FY25 Q1FY26 © Zen Technologies Limited – All Rights Reserved. 10
Slide 12: Strategic Priorities
Strategic Priorities Continue to grow the sales of Equipment Look for inorganic acquisition which fit in and expand the product portfolio with with company’s vision and positioning. strong focus on emerging space drones & Anti-Drone systems. Scale the AMC business, where the Enhance technical capabi
Slide 13: Thank You
Disclaimer: Thank Certain Statements in this presentation Let’s connect concerning our future growth prospects are forward-looking statements, which involve a number of risks and uncertainties that could You Afzal Malkani cause actual results to differ materially from those in such forward-looking s